Divergent Motifs but Overlapping Binding Repertoires of Six HLA-DQ Molecules Frequently Expressed in the Worldwide Human Population

Knowledge of the binding repertoires and specificities of HLA-DQ molecules is somewhat limited and contradictory, partly because of the scarcity of reports addressing some of the most common molecules and possibly because of the diversity of the techniques used. In this paper, we report the development of high-throughput binding assays for the six most common DQ molecules in the general worldwide population. Using comprehensive panels of single substitution analogs of specific ligands, we derived detailed binding motifs for DQA1*0501/DQB1*0301, DQA1*0401/DQB1*0402, and DQA1*0101/DQB1*0501 and more detailed motifs for DQA1*0501/DQB1*0201, DQA1*0301/DQB1*0302, and DQA1*0102/DQB1*0602, previously characterized on the basis of sets of eluted ligands and/or limited sets of substituted peptides. In contrast to what has previously been observed for DR and DP molecules, DQ motifs were generally less clearly defined in terms of chemical specificity and, strikingly, had little overlap with each other. However, testing a panel of peptides spanning a set of Phleum pratense Ags, and panels of known DQ epitopes, revealed a surprisingly significant and substantial overlap in the repertoire of peptides bound by these DQ molecules. Although the mechanism underlying these apparently contradictory findings is not clear, it likely reflects the peculiar mode of interaction between DQ (and not DR or DP) molecules and their peptide ligands. Because the DQ molecules studied are found in >85% of the general human population, these findings have important implications for epitope identification studies and monitoring of DQ-restricted immune responses.

[1]  Y. Cheng,et al.  Relationship between the inhibition constant (K1) and the concentration of inhibitor which causes 50 per cent inhibition (I50) of an enzymatic reaction. , 1973, Biochemical pharmacology.

[2]  R. Zinkernagel,et al.  H-2 compatibility is required for T-cell-mediated lysis of target cells infected with lymphocytic choriomeningitis virus , 1975, The Journal of experimental medicine.

[3]  R. Zinkernagel,et al.  A BIOLOGICAL ROLE FOR THE MAJOR HISTOCOMPATIBILITY ANTIGENS , 1975, The Lancet.

[4]  R. Zinkernagel,et al.  H-2 compatability requirement for T-cell-mediated lysis of target cells infected with lymphocytic choriomeningitis virus. Different cytotoxic T- cell specificities are associated with structures coded for in H-2K or H-2D; , 1975, The Journal of experimental medicine.

[5]  Robert P. Erickson,et al.  Natural history of the major histocompatibility complex , 1987 .

[6]  C Oseroff,et al.  On the interaction of promiscuous antigenic peptides with different DR alleles. Identification of common structural motifs. , 1991, Journal of immunology.

[7]  J. Sidney,et al.  DRB1*0301 molecules recognize a structural motif distinct from the one recognized by most DR beta 1 alleles. , 1992, Journal of immunology.

[8]  A. Hughes,et al.  Maintenance of MHC polymorphism , 1992, Nature.

[9]  D. Kwiatkowski,et al.  Maintenance of MHC polymorphism , 1992, Nature.

[10]  J. Berzofsky,et al.  Construction of an HIV-1 peptide vaccine containing a multideterminant helper peptide linked to a V3 loop peptide 18 inducing strong neutralizing antibody responses in mice of multiple MHC haplotypes after two immunizations. , 1993, Journal of immunology.

[11]  M F del Guercio,et al.  HLA DR4w4-binding motifs illustrate the biochemical basis of degeneracy and specificity in peptide-DR interactions. , 1993, Journal of immunology.

[12]  Norbert,et al.  Myelin basic protein-specific T lymphocyte repertoire in multiple sclerosis. Complexity of the response and dominance of nested epitopes due to recruitment of multiple T cell clones. , 1993, The Journal of clinical investigation.

[13]  F. Sinigaglia,et al.  Promiscuous and allele-specific anchors in HLA-DR-binding peptides , 1993, Cell.

[14]  C Oseroff,et al.  Development of high potency universal DR-restricted helper epitopes by modification of high affinity DR-blocking peptides. , 1994, Immunity.

[15]  Don C. Wiley,et al.  Crystal structure of the human class II MHC protein HLA-DR1 complexed with an influenza virus peptide , 1994, Nature.

[16]  William Arbuthnot Sir Lane,et al.  Self-peptides bound to the type I diabetes associated class II MHC molecules HLA-DQ1 and HLA-DQ8. , 1994, International immunology.

[17]  M F del Guercio,et al.  Definition of a DQ3.1-specific binding motif. , 1994, Journal of immunology.

[18]  J. Lamb,et al.  Overlapping T-cell epitopes in the group I allergen of Dermatophagoides species restricted by HLA-DP and HLA-DR class II molecules. , 1994, The Journal of allergy and clinical immunology.

[19]  Partho Ghosh,et al.  The structure of an intermediate in class II MHC maturation: CLIP bound to HLA-DR3 , 1995, Nature.

[20]  D. Madden The three-dimensional structure of peptide-MHC complexes. , 1995, Annual review of immunology.

[21]  K. Wiesmüller,et al.  Intramolecular immunodominance and intermolecular selection of H2d-restricted peptides define the same immunodominant region of the measles virus fusion protein. , 1995, Molecular immunology.

[22]  F. Sinigaglia,et al.  Motifs and supermotifs for MHC class II binding peptides , 1995, The Journal of experimental medicine.

[23]  G. Nepom,et al.  Allele-specific motifs characterize HLA-DQ interactions with a diabetes-associated peptide derived from glutamic acid decarboxylase. , 1996, Journal of immunology.

[24]  M F del Guercio,et al.  Definition of an HLA-A3-like supermotif demonstrates the overlapping peptide-binding repertoires of common HLA molecules. , 1996, Human immunology.

[25]  E. Thorsby,et al.  Binding of peptides from the N-terminal region of alpha-gliadin to the celiac disease-associated HLA-DQ2 molecule assessed in biochemical and T cell assays. , 1996, Clinical immunology and immunopathology.

[26]  H. Rammensee,et al.  The peptide binding motif of the disease associated HLA‐DQ (α 1* 0501, β 1* 0201) molecule , 1996 .

[27]  R. Zinkernagel,et al.  The discovery of MHC restriction. , 1997, Immunology today.

[28]  J. Drijfhout,et al.  Unique peptide binding characteristics of the disease-associated DQ(α1*0501, β1*0201) vs the non-disease-associated DQ(α1*0201, β1*0202) molecule , 1997, Immunogenetics.

[29]  L. Stern,et al.  The class II MHC protein HLA-DR1 in complex with an endogenous peptide: implications for the structural basis of the specificity of peptide binding. , 1997, Structure.

[30]  G Chelvanayagam,et al.  A roadmap for HLA-DR peptide binding specificities. , 1997, Human immunology.

[31]  L. Mitchell,et al.  HLA-DR restrictive supertypes dominate promiscuous T cell recognition: association of multiple HLA-DR molecules with susceptibility to autoimmune diseases. , 1997, The Journal of rheumatology.

[32]  A Sette,et al.  Two complementary methods for predicting peptides binding major histocompatibility complex molecules. , 1997, Journal of molecular biology.

[33]  L Raddrizzani,et al.  Different modes of peptide interaction enable HLA-DQ and HLA-DR molecules to bind diverse peptide repertoires. , 1997, Journal of immunology.

[34]  W. Kwok,et al.  A peptide binding motif for HLA-DQA1*0102/DQB1*0602, the class II MHC molecule associated with dominant protection in insulin-dependent diabetes mellitus. , 1998, Journal of immunology.

[35]  J. Sidney,et al.  HLA supertypes and supermotifs: a functional perspective on HLA polymorphism. , 1998, Current opinion in immunology.

[36]  W A Hendrickson,et al.  Crystal structure of I-Ak in complex with a dominant epitope of lysozyme. , 1998, Immunity.

[37]  D. Jewell,et al.  Use of complete eluted peptide sequence data from HLA-DR and -DQ molecules to predict T cell epitopes, and the influence of the nonbinding terminal regions of ligands in epitope selection. , 1998, Journal of immunology.

[38]  M F del Guercio,et al.  Several common HLA-DR types share largely overlapping peptide binding repertoires. , 1998, Journal of immunology.

[39]  L. Mitchell,et al.  A new categorization of HLA DR alleles on a functional basis. , 1998, Human immunology.

[40]  S. Buus,et al.  The P9 pocket of HLA-DQ2 (non-Aspbeta57) has no particular preference for negatively charged anchor residues found in other type 1 diabetes-predisposing non-Aspbeta57 MHC class II molecules. , 1998, International immunology.

[41]  P. A. Peterson,et al.  Crystal structures of two I-Ad-peptide complexes reveal that high affinity can be achieved without large anchor residues. , 1998, Immunity.

[42]  G. Nepom,et al.  Promiscuous T-cell recognition of a rubella capsid protein epitope restricted by DRB1*0403 and DRB1*0901 molecules sharing an HLA DR supertype. , 1998, Human immunology.

[43]  Johansen,et al.  A Peptide‐Binding Assay for the Disease‐Associated HLA‐DQ8 Molecule , 1998, Scandinavian journal of immunology.

[44]  J. Sidney,et al.  Nine major HLA class I supertypes account for the vast preponderance of HLA-A and -B polymorphism , 1999, Immunogenetics.

[45]  G. Benedek,et al.  A conformational change in the human major histocompatibility complex protein HLA-DR1 induced by peptide binding. , 1999, Biochemistry.

[46]  L. Stern,et al.  Sodium dodecyl sulfate stability of HLA-DR1 complexes correlates with burial of hydrophobic residues in pocket 1. , 1999, Journal of immunology.

[47]  John Sidney,et al.  HLA-DR-Promiscuous T Cell Epitopes from Plasmodium falciparum Pre-Erythrocytic-Stage Antigens Restricted by Multiple HLA Class II Alleles1 2 , 2000, The Journal of Immunology.

[48]  G. Benedek,et al.  Determinants of the Peptide-induced Conformational Change in the Human Class II Major Histocompatibility Complex Protein HLA-DR1* , 2000, The Journal of Biological Chemistry.

[49]  Andrew W. Liu,et al.  β57-Asp Plays an Essential Role in the Unique SDS Stability of HLA-DQA1*0102/DQB1*0602 αβ Protein Dimer, the Class II MHC Allele Associated with Protection from Insulin-Dependent Diabetes Mellitus1 , 2000, The Journal of Immunology.

[50]  F Koning,et al.  Structure of celiac disease-associated HLA-DQ8 and non-associated HLA-DQ9 alleles in complex with two disease-specific epitopes. , 2000, International immunology.

[51]  Don C. Wiley,et al.  Structure of a human insulin peptide–HLA-DQ8 complex and susceptibility to type 1 diabetes , 2001, Nature Immunology.

[52]  John Sidney,et al.  Measurement of MHC/Peptide Interactions by Gel Filtration , 1999, Current protocols in immunology.

[53]  S G Marsh,et al.  The HLA dictionary 2001: a summary of HLA-A, -B, -C, -DRB1/3/4/5, -DQB1 alleles and their association with serologically defined HLA-A, -B, -C, -DR, and -DQ antigens. , 2001, Human immunology.

[54]  John Sidney,et al.  Identification and Antigenicity of Broadly Cross-Reactive and Conserved Human Immunodeficiency Virus Type 1-Derived Helper T-Lymphocyte Epitopes , 2001, Journal of Virology.

[55]  P. Roepstorff,et al.  Celiac lesion T cells recognize epitopes that cluster in regions of gliadins rich in proline residues. , 2002, Gastroenterology.

[56]  Craig Beeson,et al.  Binding interactions between peptides and proteins of the class II Major Histocompatibility Complex , 2002, Medicinal research reviews.

[57]  John Sidney,et al.  The HLA Molecules DQA1*0501/B1*0201 and DQA1*0301/B1*0302 Share an Extensive Overlap in Peptide Binding Specificity1 , 2002, The Journal of Immunology.

[58]  Alain Sanson,et al.  HLA-DP4, the Most Frequent HLA II Molecule, Defines a New Supertype of Peptide-Binding Specificity1 , 2002, The Journal of Immunology.

[59]  J. Strominger,et al.  A pH-sensitive histidine residue as control element for ligand release from HLA-DR molecules , 2002, Proceedings of the National Academy of Sciences of the United States of America.

[60]  E. Albert,et al.  Differential peptide binding motif for three juvenile arthritis associated HLA-DQ molecules. , 2003, Clinical and experimental rheumatology.

[61]  James Robinson,et al.  IMGT/HLA and IMGT/MHC: sequence databases for the study of the major histocompatibility complex , 2003, Nucleic Acids Res..

[62]  Ian A Wilson,et al.  Crystal structure of MHC class II I-Ab in complex with a human CLIP peptide: prediction of an I-Ab peptide-binding motif. , 2003, Journal of molecular biology.

[63]  A. Sanchez‐Mazas,et al.  Geographic patterns of functional categories of HLA-DRB1 alleles: a new approach to analyse associations between HLA-DRB1 and disease. , 2003, European journal of immunogenetics : official journal of the British Society for Histocompatibility and Immunogenetics.

[64]  N. Balandraud,et al.  Functional categorization of HLA-DRB1 alleles in rheumatoid arthritis: the protective effect. , 2003, Human immunology.

[65]  E. Rosenberg,et al.  Comprehensive Analysis of Human Immunodeficiency Virus Type 1-Specific CD4 Responses Reveals Marked Immunodominance of gag and nef and the Presence of Broadly Recognized Peptides , 2004, Journal of Virology.

[66]  T. Volz,et al.  Determination of the peptide binding motif and high-affinity ligands for HLA-DQ4 using synthetic peptide libraries. , 2004, Human immunology.

[67]  Arne Svejgaard,et al.  Crystal structure of HLA-DQ0602 that protects against type 1 diabetes and confers strong susceptibility to narcolepsy , 2004, Proceedings of the National Academy of Sciences of the United States of America.

[68]  Matthew W. Anderson,et al.  A polymorphic pocket at the P10 position contributes to peptide binding specificity in class II MHC proteins. , 2004, Chemistry & biology.

[69]  O. Lund,et al.  Definition of supertypes for HLA molecules using clustering of specificity matrices , 2004, Immunogenetics.

[70]  E. Bergseng,et al.  Structural basis for HLA-DQ2-mediated presentation of gluten epitopes in celiac disease , 2004, Proceedings of the National Academy of Sciences of the United States of America.

[71]  Steve Wilson,et al.  The Immune Epitope Database and Analysis Resource: From Vision to Blueprint , 2005, PLoS biology.

[72]  Scott A. Brown,et al.  T cell epitope "hotspots" on the HIV Type 1 gp120 envelope protein overlap with tryptic fragments displayed by mass spectrometry. , 2005, AIDS research and human retroviruses.

[73]  Irini A. Doytchinova,et al.  In Silico Identification of Supertypes for Class II MHCs1 , 2005, The Journal of Immunology.

[74]  Tin Wee Tan,et al.  Structural bioinformatics Prediction of HLA-DQ 3 . 2 b Ligands : evidence of multiple registers in class II binding peptides , 2006 .

[75]  A. Ménez,et al.  Scanning the HIV Genome for CD4+ T Cell Epitopes Restricted to HLA-DP4, the Most Prevalent HLA Class II Molecule1 , 2006, The Journal of Immunology.

[76]  V. Brusic,et al.  SARS coronavirus nucleocapsid immunodominant T-cell epitope cluster is common to both exogenous recombinant and endogenous DNA-encoded immunogens , 2006, Virology.

[77]  C. Sanjeevi Genes Influencing Innate and Acquired Immunity in Type 1 Diabetes and Latent Autoimmune Diabetes in Adults , 2006, Annals of the New York Academy of Sciences.

[78]  G. Nepom,et al.  Allelic Variation in Key Peptide-Binding Pockets Discriminates between Closely Related Diabetes-Protective and Diabetes-Susceptible HLA-DQB1*06 Alleles1 , 2006, The Journal of Immunology.

[79]  Clemencia Pinilla,et al.  Characterization of the peptide-binding specificity of the chimpanzee class I alleles A*0301 and A*0401 using a combinatorial peptide library , 2007, Immunogenetics.

[80]  Bjoern Peters,et al.  HLA class I supertypes: a revised and updated classification , 2008, BMC Immunology.

[81]  Cisca Wijmenga,et al.  Genetic Background of Celiac Disease and Its Clinical Implications , 2008, The American Journal of Gastroenterology.

[82]  Morten Nielsen,et al.  Quantitative Predictions of Peptide Binding to Any HLA-DR Molecule of Known Sequence: NetMHCIIpan , 2008, PLoS Comput. Biol..

[83]  John Sidney,et al.  A Systematic Assessment of MHC Class II Peptide Binding Predictions and Evaluation of a Consensus Approach , 2008, PLoS Comput. Biol..

[84]  G. Eisenbarth,et al.  Extreme genetic risk for type 1A diabetes in the post-genome era. , 2008, Journal of autoimmunity.

[85]  Bjoern Peters,et al.  Quantitative peptide binding motifs for 19 human and mouse MHC class I molecules derived using positional scanning combinatorial peptide libraries , 2008, Immunome research.

[86]  M. Mazzilli,et al.  HLA-DQ and risk gradient for celiac disease. , 2009, Human immunology.

[87]  L. Sollid,et al.  Antigen presentation in celiac disease. , 2009, Current opinion in immunology.

[88]  M Setterholm,et al.  The HLA dictionary 2008: a summary of HLA-A, -B, -C, -DRB1/3/4/5, and -DQB1 alleles and their association with serologically defined HLA-A, -B, -C, -DR, and -DQ antigens. , 2009, Tissue antigens.

[89]  Morten Nielsen,et al.  MHC Class II epitope predictive algorithms , 2010, Immunology.

[90]  Bjoern Peters,et al.  Five HLA-DP Molecules Frequently Expressed in the Worldwide Human Population Share a Common HLA Supertypic Binding Specificity , 2010, The Journal of Immunology.